The biological activity of G-quadruplex DNA binding papaverine-derived ligand in breast cancer cells
- 289 Downloads
It was shown previously that the papaverine oxidation products 6a,12a-diazadibenzo-[a,g]fluorenylium derivative (ligand 1) and 2,3,9,10-tetramethoxy-12-oxo-12H-indolo[2,1-a]isoquinolinium chloride (ligand 2) bind to guanine-quadruplexes (G4) of single stranded G-rich 3′-overhangs of mammalian telomeric DNA. Here we show the biological activity of ligand 1. This compound exhibit antiproliferative activity in MCF-7 cells (IC50 for ligand 1 = 14.16 ± 0.01 μM, 24 h, 1.158 ± 0.056 μM, 72 h. PCNA levels were not altered after treatment of MCF-7 cells with concentrations of ligand 1 which, however, led to alterations in the cell cycle. 5 and 10 μM of the ligand 1 arrested cells in the G0/G1 phase of the cell cycle and this led to a decrease of cells in the S phase. Intracellular accumulation of ligand 1 was observed even after a cell passage and medium exchange in fluorescence microscopy while low concentrations of ligand 1 (0.001 to 0.1 μM) inhibited telomerase activity as shown by TRAP assay.
KeywordsPapaverine derivative Cell cycle arrest Breast cancer Telomerase inhibitor DNA binding G-quadruplex DNA
The present study was supported by the Joint Research Grant from Adam Mickiewicz University and Poznan University of Medical Sciences, Poznan, Poland and by N N401 223 534 research grant.
- 1.Haince JF, Kozlov S, Dawson VL, Dawson TM, Hendzel MJ, Lavin MF et al (2007) Ataxia telangiectasia mutated (ATM) signaling network is modulated by a novel poly(ADP-ribose)-dependent pathway in the early response to DNA-damaging agents. J Biol Chem 282:16441–16453. doi: 10.1074/jbc.M608406200 PubMedCrossRefGoogle Scholar
- 2.Kontopidis G, Wu SY, Zheleva DI, Taylor P, McInnes C, Lane DP et al (2005) Structural and biochemical studies of human proliferating cell nuclear antigen complexes provide a rationale for cyclin association and inhibitor design. Proc Natl Acad Sci U S A 102:1871–1876. doi: 10.1073/pnas.0406540102 PubMedCrossRefGoogle Scholar
- 12.Burger AM, Dai F, Schultes CM, Reszka AP, Moore MJ, Double JA et al (2005) The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function. Cancer Res 65:1489–1496. doi: 10.1158/0008-5472.CAN-04-2910 PubMedCrossRefGoogle Scholar
- 18.Pennarun G, Granotier C, Gauthier LR, Gomez D, Hoffschir F, Mandine E et al (2005) Apoptosis related to telomere instability and cell cycle alterations in human glioma cells treated by new highly selective G-quadruplex ligands. Oncogene 24:2917–2928. doi: 10.1038/sj.onc.1208468 PubMedCrossRefGoogle Scholar
- 20.Leonetti C, Amodei S, D, Angelo C, Rizzo A, Benassi B, Antonelli A et al (2004) Biological activity of the G-quadruplex ligand RHPS4 (3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) is associated with telomere capping alteration. Mol Pharmacol 66:1138–1146. doi: 10.1124/mol.104.001537 PubMedCrossRefGoogle Scholar
- 24.Drozdzik M, Mysliwiec K, Lewinska-Chelstowska M, Banach J, Drozdzik A, Grabarek J (2004) P-glycoprotein drug transporter MDR1 gene polymorphism in renal transplant patients with and without gingival overgrowth. J Clin Periodontol 31:758–763. doi: 10.1111/j.1600-051x.2004.00554.x PubMedCrossRefGoogle Scholar